17,881 resources
By Version
By Realm
Start Prev Rows 10600 - 10800 Next
| Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Source(s) |
|---|---|---|---|---|---|---|---|---|---|
| hl7.terminology | R5 | v3-ObservationType | ObservationType | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | questionnaire-usage-mode | QuestionnaireItemUsageMode | draft | fhir | 2020-02 | uv | tho | |
| hl7.terminology | R5 | v3-ParticipationMode | ParticipationMode | active | 2014-03 | uv | tho | ||
| signal.core.r4 | R4 | questionnaire-dacods-source-of-payment-for-treatment | Questionnaire DACODS Source Of Payment For Treatment | draft | 1 | pa | us | ||
| signal.core.r4 | R4 | identifier-use | IdentifierUse | draft | 0 | fhir | 2019-10 | us | fhir |
| hl7.terminology | R5 | v3-ActIneligibilityReason | ActIneligibilityReason | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | v3-ActAccommodationReason | ActAccommodationReason | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | v3-ParticipationTypeCDASectionOverride | ParticipationTypeCDASectionOverride | active | 2014-03 | uv | tho | ||
| signal.core.r4 | R4 | questionnaire-dacods-sexual-orientation | Questionnaire DACODS Sexual Orientation | draft | 1 | pa | us | ||
| hl7.terminology | R5 | v3-MedicationGeneralizationRoleType | MedicationGeneralizationRoleType | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | v3-DocumentStorage | DocumentStorage | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | v3-QueryPriority | QueryPriority | active | 2014-03 | uv | tho | ||
| hl7.fhir.us.insurance-card | R4 | C4DICCoverageIdentifierType | C4DIC Coverage Identifier Type | active | claims | 2024-04 | us | fhir tho | |
| hl7.fhir.us.carin-bb | R4 | C4BBPatientIdentifierType | C4BB Patient Identifier Type Value Set | trial-use | fm | 2025-02 | us | fhir tho | |
| hl7.fhir.us.carin-bb | R4 | C4BBOrganizationIdentifierType | C4BB Organization Identifier Type Value Set | trial-use | fm | 2025-02 | us | fhir tho | |
| hl7.fhir.us.carin-bb | R4 | C4BBPractitionerIdentifierType | C4BB Practitioner Identifier Type Value Set | trial-use | fm | 2025-02 | us | tho | |
| hl7.terminology | R5 | v3-ActSpecObsCode | ActSpecObsCode | active | 2014-03 | uv | tho | ||
| hl7.fhir.us.carin-bb | R4 | C4BBPayeeType | C4BB Payee Type Value Set | trial-use | fm | 2025-02 | us | fhir tho | |
| hl7.terminology | R5 | v3-ActObservationVerificationType | ActObservationVerificationType | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | v3-ActDetectedIssueCode | ActDetectedIssueCode | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | v3-ActSuppliedItemDetectedIssueCode | ActSuppliedItemDetectedIssueCode | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | v3-ActAdministrativeDetectedIssueCode | ActAdministrativeDetectedIssueCode | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | v3-ActPharmacySupplyType | ActPharmacySupplyType | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | v3-ActMonitoringProtocolCode | ActMonitoringProtocolCode | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | v3-SubstitutionCondition | SubstitutionCondition | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | v3-ControlActReason | ControlActReason | active | 2014-03 | uv | tho | ||
| hl7.eu.fhir.idea4rc | R4 | mitotic-index-athena-vs | Mitotic Index: Athena. | draft | 2025-07 | eu | |||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1237.22 | Medicinal Ingredients RXNORM | active | 2024-01 | us | rx | ||
| signal.core.r4 | R4 | questionnaire-dacods-tobacco-use | Questionnaire DACODS Tobacco Use | draft | 1 | pa | us | ||
| hl7.eu.fhir.idea4rc | R4 | mcode-observation-codes-distant-metastases-vs | Observation Codes for Distant Metastases Category | draft | 2025-07 | eu | loinc | ||
| hl7.eu.fhir.pcsp | R4 | mcode-observation-codes-distant-metastases-vs | Observation Codes for Distant Metastases Category | draft | 2025-08 | eu | loinc | ||
| hl7.eu.fhir.idea4rc | R4 | mcode-observation-codes-primary-tumor-vs | Observation Codes for Primary Tumor Category | draft | 2025-07 | eu | loinc | ||
| hl7.eu.fhir.pcsp | R4 | mcode-observation-codes-primary-tumor-vs | Observation Codes for Primary Tumor Category | draft | 2025-08 | eu | loinc | ||
| hl7.eu.fhir.idea4rc | R4 | mcode-observation-codes-regional-nodes-vs | Observation Codes for Regional Node Category | draft | 2025-07 | eu | loinc | ||
| hl7.eu.fhir.pcsp | R4 | mcode-observation-codes-regional-nodes-vs | Observation Codes for Regional Node Category | draft | 2025-08 | eu | loinc | ||
| hl7.eu.fhir.idea4rc | R4 | cancer-stageGrading-athena-vs | Cancer Stage Grading: Athena | draft | 2025-07 | eu | |||
| hl7.eu.fhir.idea4rc | R4 | cancer-stageGroup-athena-vs | Cancer Stage Group: Athena | draft | 2025-07 | eu | |||
| hl7.eu.fhir.pcsp | R4 | mcode-observation-codes-stage-group-vs | Observation Codes for Stage Group Category | draft | 2025-08 | eu | loinc | ||
| hl7.eu.fhir.idea4rc | R4 | positive-negative-notest-athena-vs | Positive-Negative-No Test: Athena | draft | 2025-07 | eu | |||
| hl7.fhir.us.mcode | R4 | mcode-tnm-regional-nodes-staging-type-vs | TNM Regional Nodes Staging Type Value Set | active | 4 | cic | 2025-02 | us | sct |
| hl7.fhir.us.mcode | R4 | mcode-tnm-stage-group-staging-type-vs | TNM Stage Group Staging Type Value Set | active | 4 | cic | 2025-02 | us | sct |
| hl7.fhir.us.mcode | R4 | mcode-tnm-distant-metastases-staging-type-vs | TNM Distant Metastases Staging Type Value Set | active | 4 | cic | 2025-02 | us | sct |
| hl7.fhir.us.mcode | R4 | mcode-tnm-primary-tumor-staging-type-vs | TNM Primary Tumor Staging Type Value Set | active | 4 | cic | 2025-02 | us | sct |
| hl7.eu.fhir.idea4rc | R4 | cancer-stageGroupValue-athena-vs | Cancer Stage Group Value: Athena | draft | 2025-07 | eu | internal | ||
| hl7.eu.fhir.idea4rc | R4 | cancer-stageGroupValue-clinical-athena-vs | Cancer Stage Group Value Clinical: Athena | draft | 2025-07 | eu | |||
| hl7.eu.fhir.idea4rc | R4 | cancer-stageGroupValue-pathological-athena-vs | Cancer Stage Group Value Pathological: Athena | draft | 2025-07 | eu | |||
| ee.hl7.fhir.base.r5 | R5 | ee-organization-identity | Organization Identity System | draft | 2023-08 | ee | internal | ||
| ee.hl7.fhir.base.r5 | R5 | ee-patient-identity | Person Identity System | draft | 2023-08 | ee | internal | ||
| ee.fhir.terminology | R5 | patient-identifier-domain | Patient Identifier Domain | active | 2025-06 | ee | internal | ||
| ee.hl7.fhir.base.r5 | R5 | ee-practitioner-identity | Practitioner Identity System | draft | 2023-08 | ee | internal | ||
| hl7.terminology | R5 | v3-ImageMediaType | ImageMediaType | active | 2014-03 | uv | tho | ||
| hl7.fhir.eu.imaging-manifest-r5 | R5 | im-imaging-device-type | Imaging Device Type | draft | 2025-07 | eu | sct | ||
| hl7.fhir.eu.imaging-r5 | R5 | im-imaging-device-type | Imaging Device Type | draft | 2025-08 | eu | sct | ||
| hl7.fhir.eu.imaging-manifest-r5 | R5 | im-imaging-study-performer-type | Imaging Study Performer Type Value Set | draft | 2025-07 | eu | fhir tho | ||
| hl7.fhir.eu.imaging-r5 | R5 | im-imaging-study-performer-type | Imaging Study Performer Type Value Set | draft | 2025-08 | eu | fhir tho | ||
| hl7.fhir.cz.img | R4 | cz-imaging-study-performer-type | Imaging Study Performer Type Value Set | draft | 2025-08 | cz | fhir tho | ||
| ch.fhir.ig.ch-term | R4 | ch-vacd-ch-vaccination-plan-immunizations-vs | CH VACD Swiss Vaccination Plan Immunizations | active | 2025-05 | ch | sct | ||
| ch.fhir.ig.ch-term | R4 | ch-vacd-recommendation-categories-vs | CH VACD Recommendation Categories for Immunizations | active | 2025-05 | ch | sct | ||
| ch.fhir.ig.ch-term | R4 | ch-vacd-recommendation-forecast-status-vs | CH VACD Swiss Recommendation Forecast Status | active | 2025-05 | ch | |||
| hl7.terminology | R5 | v2-0441 | hl7VS-immunizationRegistryStatus | active | 2019-12 | uv | tho | ||
| hl7.terminology | R5 | v3-Implantation | Implantation | active | 2014-03 | uv | tho | ||
| ch.fhir.ig.ch-epr-fhir | R4 | AccessAuditTrailEventType | AccessAuditTrailEventType | draft | 2018-05 | ch | oid | ||
| ch.fhir.ig.ch-epr-fhir | R4 | DocumentAuditEventType | DocumentAuditEventType | draft | 2018-05 | ch | oid | ||
| ch.fhir.ig.ch-epr-fhir | R4 | EprParticipant | EprParticipant | draft | 2018-05 | ch | oid | ||
| ch.fhir.ig.ch-epr-fhir | R4 | HpdAuditEventType | HpdAuditEventType | draft | 2022-06 | ch | oid | ||
| ch.fhir.ig.ch-epr-fhir | R4 | PolicyAuditEventType | PolicyAuditEventType | draft | 2018-05 | ch | oid | ||
| ch.fhir.ig.ch-atc | R4 | AccessAuditTrailEventType | AccessAuditTrailEventType | draft | 2018-05 | ch | oid | ||
| ch.fhir.ig.ch-atc | R4 | DocumentAuditEventType | DocumentAuditEventType | draft | 2018-05 | ch | oid | ||
| ch.fhir.ig.ch-atc | R4 | EprParticipant | EprParticipant | draft | 2018-05 | ch | oid | ||
| ch.fhir.ig.ch-atc | R4 | HpdAuditEventType | HpdAuditEventType | draft | 2022-06 | ch | oid | ||
| ch.fhir.ig.ch-atc | R4 | PolicyAuditEventType | PolicyAuditEventType | draft | 2018-05 | ch | oid | ||
| hl7.fhir.us.vdor | R4 | nvdrs-document-types-vs | NVDRS Document Types | informative | pher | 2025-06 | us | fhir | |
| hl7.fhir.uv.vhdir | R4 | digitalcertificatetype | VhDir Digital Certificate Type Value Set | trial-use | 2 | pa | 2018-02 | uv | fhir |
| hl7.fhir.us.davinci-pas | R4 | pas-pwk01-attachment-report-type-code | PAS PWK01 Attachment Report Type Code Value Set | trial-use | 3 | fm | 2024-05 | us | x12 |
| hl7.fhir.us.davinci-cdex | R4 | cdex-pwk01-attachment-report-type-code | CDex PWK01 Attachment Report Type Code Value Set | trial-use | 2 | claims | 2024-05 | us | x12 |
| hl7.terminology | R5 | v3-ParticipationBaby | ParticipationBaby | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | v3-ParticipationDonor | ParticipationDonor | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | v3-Ethnicity | Ethnicity | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | v3-Race | Race | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | v3-NUCCProviderCodes | NUCCProviderCodes | active | 2014-03 | uv | nucc | ||
| fhir.cqf.common | R4 | inactive-condition | CQF Inactive Condition | active | 2019-07 | us | tho | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.85 | Nutrition Diagnosis Grouping | active | 2024-05 | us | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.70 | Nutrition Education SNOMED CT | active | 2020-09 | us | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.82 | Food and Nutrition Related History Grouping | active | 2022-03 | us | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1248.241 | Degenerative Neurological Disorder | active | 2023-09 | us | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1248.239 | Neuromuscular Disorder | active | 2023-09 | us | vsac | ||
| hl7.terminology | R5 | v3-ActAdjudicationCode | ActAdjudicationCode | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | v3-ActInvoiceOverrideCode | ActInvoiceOverrideCode | active | 2014-03 | uv | tho | ||
| hl7.fhir.us.registry-protocols | R4 | NewYorkHeartAssociation | New York Heart Association Assessment Scale | active | cic | 2023-11 | us | sct loinc | |
| hl7.fhir.us.pacio-adi | R4 | ADINoHealthcareAgentIncludedReasonVS | No Healthcare Agent Included Reason | trial-use | 2 | pe | 2025-08 | us | tho |
| fhir.cdc.opioid-cds-r4 | R4 | medicationrequest-category-community | ValueSet - Medication Request Category Community | active | 2025-08 | us | |||
| hl7.fhir.us.mcode | R4 | mcode-cancer-related-surgical-procedure-vs | Cancer-Related Surgical Procedure Value Set | active | 3 | cic | 2025-02 | us | sct cpt cms |
| hl7.fhir.uv.livd | R4 | testcode-mappings-livd | Test code mappings value set for LIVD | active | 2018-09 | uv | loinc | ||
| hl7.fhir.us.vdor | R4 | vdor-drug-misuse-vs | VDOR Indicated Prescription Drug Misuse or Illicit Drug Use | informative | pher | 2025-06 | us | fhir | |
| hl7.fhir.us.carin-bb | R4 | C4BBInstitutionalClaimSubType | C4BB Institutional Claim SubType Value Set | trial-use | fm | 2025-02 | us | fhir | |
| hl7.fhir.us.carin-bb | R4 | C4BBClaimInpatientInstitutionalDiagnosisType | C4BB Claim Inpatient Institutional Diagnosis Type Value Set | trial-use | fm | 2025-02 | us | fhir tho | |
| hl7.fhir.us.carin-bb | R4 | C4BBClaimProcedureType | C4BB Claim Procedure Type Value Set | trial-use | fm | 2025-02 | us | fhir | |
| hl7.fhir.us.carin-bb | R4 | C4BBClaimOutpatientInstitutionalDiagnosisType | C4BB Claim Outpatient Institutional Diagnosis Type Value Set | trial-use | fm | 2025-02 | us | fhir tho | |
| hl7.fhir.us.carin-bb | R4 | C4BBClaimProfessionalAndNonClinicianDiagnosisType | C4BB Claim Professional And Non Clinician Diagnosis Type Value Set | trial-use | fm | 2025-02 | us | fhir tho | |
| hl7.fhir.uv.extensions | R5 | synchronicity-control | Operation Synchronicity Control ValueSet | normative | 5 | fhir | 2020-12 | uv | fhir |
| hl7.fhir.us.carin-bb | R4 | C4BBClaimIdentifierType | C4BB Claim Identifier Type Value Set | trial-use | fm | 2025-02 | us | fhir | |
| hl7.terminology | R5 | v3-ActRelationshipProvidesEvidenceFor | ActRelationshipProvidesEvidenceFor | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | v3-ParticipationParticipation | ParticipationParticipation | active | 2014-03 | uv | tho | ||
| hl7.fhir.us.davinci-pct | R4 | PCTPayerProviderNetworkStatusVS | PCT Payer Provider Network Status | trial-use | fm | 2025-08 | us | fhir | |
| hl7.fhir.us.davinci-pdex | R4 | PriorAuthServiceTypeCodes | Prior Authorization Service Type Codes (X12) | informative | fm | 2025-06 | us | x12 | |
| hl7.fhir.uv.extensions | R5 | valueset-fallBackAction | Fallback Action ValueSet | trial-use | 1 | oo | 2025-07 | uv | fhir |
| hl7.terminology | R5 | conformance-expectation | ConformanceExpectation | draft | fhir | 2020-02 | uv | tho | |
| hl7.terminology | R5 | v3-AdministrableDrugForm | AdministrableDrugForm | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | v3-MessageWaitingPriority | MessageWaitingPriority | active | 2014-03 | uv | tho | ||
| hl7.fhir.us.davinci-pct | R4 | PCTPayerBenefitPaymentStatusVS | PCT Payer Benefit Payment Status | trial-use | fm | 2025-08 | us | fhir | |
| hl7.fhir.us.carin-bb | R4 | C4BBPayerBenefitPaymentStatus | C4BB Payer Benefit Payment Status Value Set | trial-use | fm | 2025-02 | us | fhir | |
| hl7.fhir.us.davinci-pdex | R4 | PDexPayerBenefitPaymentStatus | PDex Payer Benefit Payment Status | informative | fm | 2025-06 | us | fhir | |
| hl7.terminology | R5 | goal-priority | Goal priority | active | pc | 2024-04 | uv | tho | |
| hl7.fhir.uv.extensions.r4b | R4B | version-algorithm | Version Algorithm | trial-use | 5 | fhir | 2020-12 | uv | fhir |
| signal.core.r4 | R4 | questionnaire-dacods-discharge-status | Questionnaire DACODS Discharge Status | draft | 1 | pa | us | ||
| signal.core.r4 | R4 | questionnaire-dacods-reason-for-discharge | Questionnaire Dacods Reason For Discharge | draft | 2023-09 | us | |||
| signal.core.r4 | R4 | questionnaire-ccars-reason-for-discharge | Questionnaire CCARS Reason For Discharge | draft | 1 | pa | us | ||
| hl7.terminology | R5 | research-subject-state | ResearchSubjectState | active | 1 | brr | 2024-04 | uv | tho |
| hl7.terminology | R5 | research-subject-milestone | ResearchSubjectMilestone | active | 1 | brr | 2024-04 | uv | tho |
| hl7.fhir.us.carin-bb | R4 | C4BBPayerProviderNetworkStatus | C4BB Payer Provider Network Status Value Set | trial-use | fm | 2025-02 | us | fhir | |
| hl7.terminology | R5 | v3-AllergyTestValue | AllergyTestValue | active | 2014-03 | uv | tho | ||
| hl7.fhir.us.davinci-pct | R4 | PCTAEOBProcessNoteVS | PCT AEOB Process Note Types | trial-use | fm | 2025-08 | us | fhir | |
| ca.on.oh.mha-pds | R4 | ValueSet.ca-on-mha-ReferralType | Referral Type | active | 2022-08 | ca | |||
| hl7.terminology | R5 | codesystem-altcode-kind | AlternativeCodeKind | draft | vocab | 2020-02 | uv | tho | |
| hl7.terminology | R5 | composition-altcode-kind | AlternativeCodeKind | draft | sd | 2020-02 | uv | tho | |
| hl7.terminology | R5 | v3-NonDrugAgentEntity | NonDrugAgentEntity | active | 2014-03 | uv | tho | ||
| hl7.fhir.uv.extensions | R5 | detectedissue-doseType | DetectedIssue Dose Type VS | trial-use | 1 | cds | 2025-07 | uv | fhir |
| signal.core.r4 | R4 | location-mode | LocationMode | trial-use | 3 | pa | 2019-10 | us | fhir |
| signal.core.r4 | R4 | account-status | AccountStatus | trial-use | 2 | pa | 2019-10 | us | fhir |
| hl7.fhir.us.carin-bb | R4 | C4BBPayerClaimPaymentStatusCode | C4BB Payer Claim Payment Status Code Value Set | trial-use | fm | 2025-02 | us | fhir | |
| signal.core.r4 | R4 | location-status | LocationStatus | trial-use | 3 | pa | 2019-10 | us | fhir |
| hl7.terminology | R5 | v3-ModifyIndicator | ModifyIndicator | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | v3-ActSupplyFulfillmentRefusalReason | ActSupplyFulfillmentRefusalReason | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | v3-ModifyPrescriptionReasonType | ModifyPrescriptionReasonType | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | v3-StatusRevisionRefusalReasonCode | StatusRevisionRefusalReasonCode | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | state-change-reason | StateChangeReason | draft | 1 | brr | 2020-02 | uv | tho |
| hl7.terminology | R5 | v3-ActCoverageAuthorizationConfirmationCode | ActCoverageAuthorizationConfirmationCode | active | 2014-03 | uv | tho | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1222.580 | NYHA Heart Failure Functional Classifications | active | 2024-09 | us | sct | ||
| hl7.fhir.us.breastcancer | R3 | cimi-context-DeltaFlagVS | BC DeltaFlagVS ValueSet | draft | 2018-08 | us | sct | ||
| hl7.fhir.it.terminology | R4 | vs-aifa-nota | AIFA Note | active | 2025-06 | it | internal | ||
| hl7.fhir.us.directory-query | R4 | IndividualSpecialtyAndDegreeLicenseCertificateVS | Individual Specialties, Degrees, Licenses, and Certificates Value Set | active | 2022-12 | us | tho | ||
| hl7.fhir.us.davinci-pdex-plan-net | R4 | IndividualSpecialtyAndDegreeLicenseCertificateVS | Individual Specialties, Degrees, Licenses, and Certificates VS | trial-use | fm | 2025-02 | us | fhir tho | |
| hl7.fhir.us.ndh | R4 | IndividualSpecialtyAndDegreeLicenseCertificateVS | Individual Specialties, Degrees, Licenses, and Certificates Value Set | trial-use | pa | 2025-07 | us | fhir tho | |
| hl7.fhir.us.directory-query | R4 | IndividualAndGroupSpecialtiesVS | Individual and Group Specialties | active | 2022-12 | us | nucc | ||
| hl7.fhir.us.davinci-pdex-plan-net | R4 | IndividualAndGroupSpecialtiesVS | Individual and Group Specialties | trial-use | fm | 2025-02 | us | nucc | |
| hl7.fhir.us.ndh | R4 | IndividualAndGroupSpecialtiesVS | Individual and Group Specialties | trial-use | pa | 2025-07 | us | nucc | |
| fhir.cdc.opioid-cds-r4 | R4 | non-opioid-urine-drug-screening | Non-opioid drug urine screening | active | 2023-05 | us | loinc | ||
| fhir.cdc.opioid-cds-r4 | R4 | opioid-urine-drug-screening | Opioid drug urine screening | active | 2023-05 | us | loinc | ||
| fhir.cdc.opioid-cds-r4 | R4 | xylazine-urine-drug-screening-tests | Xylazine drug urine screening tests | active | 2024-05 | us | loinc | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.2 | Food and Nutrient Delivery SNOMED CT | active | 2025-05 | us | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.227 | Findings Related to Medication Management, Infectious Disease Symptoms | active | 2021-03 | us | sct | ||
| signal.core.r4 | R4 | questionnaire-ccars-current-living-arrangement | Questionnaire CCARS Current Living Arrangement | draft | 1 | pa | us | ||
| hl7.terminology | R5 | v3-ParticipationPrimaryInformationRecipient | ParticipationPrimaryInformationRecipient | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | v3-CUILabel | CUILabel | active | 2019-03 | uv | tho | ||
| hl7.terminology | R5 | v3-CUI | CUI | active | 2019-03 | uv | tho | ||
| hl7.terminology | R5 | v3-AskedButUnknown | AskedButUnknown | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | v3-Infusion | Infusion | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | v3-IntravenousInfusion | IntravenousInfusion | active | 2014-03 | uv | tho | ||
| nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.10.2.1--20171231000000 | InfuuskatheterTypeCodelijst | active | nl | fhir sct | |||
| hl7.fhir.uv.emedicinal-product-info | R5 | ingredientRole | Ingredient Role | active | 2025-07 | uv | fhir | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1010.7 | Clinical Drug Ingredient | active | 2024-06 | us | rx | ||
| hl7.terminology | R5 | v3-Inhalation | Inhalation | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | v3-NasalInhalation | NasalInhalation | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | v3-NebulizationInhalation | NebulizationInhalation | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | v3-OralInhalation | OralInhalation | active | 2014-03 | uv | tho | ||
| hl7.fhir.us.pacio-adi | R4 | ADIInitialTreatmentPMOOptionsVS | Initial Treatment Portable Medical Order Options | trial-use | 2 | pe | 2025-08 | us | vsac |
| fhir.virtually.healthcare | R4 | BARSReferralCode | BARS Referral Code | draft | 2025-08 | us | sct | ||
| hl7.terminology | R5 | v3-Injection | Injection | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | v3-IntraarterialInjection | IntraarterialInjection | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | v3-IntracardiacInjection | IntracardiacInjection | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | v3-IntracoronaryInjection | IntracoronaryInjection | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | v3-IntramuscularInjection | IntramuscularInjection | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | v3-IntravenousInjection | IntravenousInjection | active | 2014-03 | uv | tho | ||
| openehr.base | R5 | input-type | Input Type ValueSet | informative | 3 | fhir | 2024-08 | uv | |
| hl7.terminology | R5 | v3-Insertion | Insertion | active | 2014-03 | uv | tho | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.308 | Cardiovascular disease 10Y risk | active | 2024-02 | us | loinc | ||
| hl7.terminology | R5 | v3-Instillation | Instillation | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | v3-RectalInstillation | RectalInstillation | active | 2014-03 | uv | tho | ||
| hl7.fhir.cl.minsal.eis | R4 | VSInstitucionEmiteEspecialidad | InstituciónEmiteEspecialidad | active | 2023-01 | cl | internal | ||
| hl7.terminology | R5 | v3-Institution | Institution | active | 2014-03 | uv | tho | ||
| openehr.base | R5 | instruction-states | Instruction States | informative | 3 | fhir | 2024-08 | uv | |
| openehr.base | R5 | instruction-transitions | Instruction Transitions | informative | 3 | fhir | 2024-08 | uv | |
| openehr.base | R5 | integrity-check-algorithms | Integrity check algorithms | informative | 3 | fhir | 2024-04 | uv | |
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1021.41 | MDP Test HL7 Intensional | active | 2019-01 | us | tho | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.266 | Rhabdomyolysis Intensional | active | 2024-06 | us | sct | ||
| hl7.fhir.us.vrdr | R4 | vrdr-intentional-reject-vs | Intentional Reject ValueSet | active | pher | 2024-10 | us | fhir | |
| hl7.terminology | R5 | v3-InterameningealRoute | InterameningealRoute | active | 2014-03 | uv | tho | ||
| hl7.fhir.us.mcode | R4 | mcode-rhabdomyosarcoma-clinical-group-value-vs | Rhabdomyosarcoma Clinical Group Value | active | cic | 2025-02 | us | ncit sct | |
| hl7.eu.fhir.pcsp | R4 | vs-iccc3-eu-pcsp | ICCC-3 | draft | 2025-08 | eu | internal tho | ||
| basisprofil.de | R3 | ValueSet-dimdi-icd-10-gm | icd-10-gm | draft | 2017-09 | ||||
| hl7.terminology | R5 | v3-Charset | Charset | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | v3-MediaType | MediaType | active | 2014-03 | uv | tho | ||
| nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.3.3--20200901000000 | InterpretatieFrequentieCodelijst | active | nl | sct | |||
| nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.7--20200901000000 | InterpretatieVlaggenCodelijst | active | nl | sct | |||
| nictiz.fhir.nl.stu3.zib2017 | R3 | 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.7--20171231000000 | InterpretatieVlaggenCodelijst | active | nl | sct | |||
| hl7.terminology | R5 | v3-ObservationInterpretationNormalityHigh | ObservationInterpretationNormalityHigh | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | v3-ObservationInterpretationNormalityLow | ObservationInterpretationNormalityLow | active | 2014-03 | uv | tho | ||
| hl7.terminology | R5 | v3-ObservationInterpretationNormalityCriticallyAbnormal | ObservationInterpretationNormalityCriticallyAbnormal | active | 2019-03 | uv | tho | ||
| hl7.fhir.us.breastcancer | R3 | shr-core-PositiveNegativeEquivocalIndeterminateVS | BC PositiveNegativeEquivocalIndeterminateVS ValueSet | draft | 2018-08 | us | sct | ||
| hl7.terminology | R5 | v3-ObservationInterpretationNormalityAbnormal | ObservationInterpretationNormalityAbnormal | active | 2014-03 | uv | tho |
FHIR